Tubulis
Moetaz Albizem currently serves as Senior Vice President and Head of Clinical Operations at Tubulis GmbH, with prior experience in the same role at Aerium Therapeutics. With over 15 years of global clinical development experience, Moetaz has held significant positions at leading pharmaceutical companies, including Executive Director at Regeneron and Incyte, as well as Director at Amgen. Expertise includes designing and managing all phases of clinical trials, budget and resource management, and interactions with Key Opinion Leaders. Moetaz has a medical degree from Belarusian State Medical University, further enhancing a comprehensive background in clinical operations and regulatory compliance.
This person is not in any offices
Tubulis
2 followers
Tubulis generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Their goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients. They will advance a range of conjugates, unlimited by indication, using their own discovery capabilities and by solving development challenges for partners with both antibody and chemical assets.